论文部分内容阅读
目的:观察并探讨痰热清注射液作为辅助方法治疗急性支气管肺炎的临床效果。方法:选择我院2011年5月至2013年12月86例急性支气管炎患者作为观察对象,随机将患者分为治疗组(43例)和对照组(43例)。两组患者入院后均进行常规对症治疗,对照组采用抗生素进行治疗,在此基础上给予治疗组患者痰热清注射液,比较两组患者临床治疗效果、治疗前后血清CRP水平以及不良反应。结果:治疗组总有效率为95.3%,显著高于对照组(76.8%),两组比较,差异具有统计学意义(P<0.05);两组治疗后血清CRP水平均较治疗前有所下降,P<0.05。治疗组改善程度更为明显,与对照组治疗后比较,P<0.05;两组患者均未产生明显不良反应。结论:痰热清注射液作为急性支气管炎辅助治疗药物,可明显提升治疗效果,改善临床症状,并有效减少血清CRP浓度,值得推广。
Objective: To observe and discuss the clinical effect of Tanreqing Injection as an adjunct to treat acute bronchial pneumonia. Methods: A total of 86 patients with acute bronchitis from May 2011 to December 2013 in our hospital were selected as observation subjects. Patients were randomly divided into treatment group (43 cases) and control group (43 cases). Both groups were given routine symptomatic treatment after admission. Patients in the control group were treated with antibiotics. On the basis of this, Tanreqing injection was given to the patients in the treatment group. The clinical effect, the serum CRP level and the adverse reactions before and after treatment were compared between the two groups. Results: The total effective rate of the treatment group was 95.3%, which was significantly higher than that of the control group (76.8%). There was significant difference between the two groups (P <0.05). The serum CRP level decreased after treatment in both groups , P <0.05. The treatment group improved more significantly, compared with the control group after treatment, P <0.05; two groups of patients did not produce significant adverse reactions. Conclusion: Tanreqing injection as adjuvant treatment of acute bronchitis can significantly improve the therapeutic effect, improve clinical symptoms, and effectively reduce serum CRP concentration, it is worth promoting.